Cargando…

Usefulness of colestimide for diarrhea in postoperative Crohn's disease

BACKGROUND AND AIM: Crohn's disease (CD) often causes intractable diarrhea after intestinal resection. Anion exchange resins have been reported to be effective in patients with bile acid diarrhea after distal ileectomy; furthermore, bile acid metabolism has been implicated in the pathogenesis o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hojo, Aya, Kobayashi, Taku, Matsubayashi, Mao, Morikubo, Hiromu, Miyatani, Yusuke, Fukuda, Tomohiro, Asonuma, Kunio, Sagami, Shintaro, Nakano, Masaru, Matsuda, Takahisa, Hibi, Toshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344577/ https://www.ncbi.nlm.nih.gov/pubmed/35928696 http://dx.doi.org/10.1002/jgh3.12786

Ejemplares similares

Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn’s Disease
por: Asonuma, Kunio, et al.
Publicado: (2023)

Development of algorithms for identifying patients with Crohn’s disease in the Japanese health insurance claims database
por: Morikubo, Hiromu, et al.
Publicado: (2021)

Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease
por: Sagami, Shintaro, et al.
Publicado: (2019)

Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis
por: Okabayashi, Shinji, et al.
Publicado: (2019)

A case of sitosterolemia due to compound heterozygous mutations in ABCG5: clinical features and treatment outcomes obtained with colestimide and ezetimibe
por: Ono, Sahoko, et al.
Publicado: (2017)

Effect of colestimide on the concentrations of polychlorinated dibenzo-p-dioxins, polychlorinated dizenzofurans, and polychlorinated biphenyls in blood of Yusho patients
por: Todaka, Takashi, et al.
Publicado: (2016)

Post‐marketing analysis for biosimilar CT‐P13 in inflammatory bowel disease compared with external data of originator infliximab in Japan
por: Sagami, Shintaro, et al.
Publicado: (2021)

Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2021)

Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome
por: Toyonaga, Takahiko, et al.
Publicado: (2017)

A Case of Crohn’s Disease with Cardiac Tamponade Caused by Tuberculous Pericarditis: Assessment of a Rare Phenomenon
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial
por: Fukushima, Yasushi, et al.
Publicado: (2012)

Endoscopic and Pathologic Changes of the Upper Gastrointestinal Tract in Crohn's Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2014)

Improving IBD outcomes in the era of many treatment options
por: Kobayashi, Taku, et al.
Publicado: (2023)

Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
por: Okamoto, Hiroyuki, et al.
Publicado: (2021)

Postoperative diarrhea in Crohn’s disease: Pathogenesis, diagnosis, and therapy
por: Wu, En-Hao, et al.
Publicado: (2023)

First aid with color atlas for the use of intestinal ultrasound for inflammatory bowel disease in daily clinical practice
por: Miyoshi, Jun, et al.
Publicado: (2023)

Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn’s Disease
por: Suzuki, Yasuo, et al.
Publicado: (2016)

Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan
por: Ueno, Fumiaki, et al.
Publicado: (2012)

Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn’s Disease
por: Ogata, Haruhiko, et al.
Publicado: (2016)

Inflammatory Bowel Disease in Japan -Is It Similar to or Different from Westerns?-
por: Okabayashi, Shinji, et al.
Publicado: (2020)

Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis
por: Tsuboi, Rumiko, et al.
Publicado: (2018)

Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab
por: Okabayashi, Shinji, et al.
Publicado: (2017)

Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies
por: Hibi, Toshifumi, et al.
Publicado: (2017)

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
por: Yagisawa, Keiji, et al.
Publicado: (2019)

Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
por: Yagisawa, Keiji, et al.
Publicado: (2020)

Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis
por: Kobayashi, Taku, et al.
Publicado: (2020)

Performing colonoscopy before steroid induction is associated with shorter steroid use in patients with ulcerative colitis
por: Kobayashi, Taku, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
por: Kobayashi, Taku, et al.
Publicado: (2023)

Efficacy and suitable indication of colorectal endoscopic submucosal dissection using a balloon‐assisted endoscope
por: Kuroki, Yuichiro, et al.
Publicado: (2019)

De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
por: Miyatani, Yusuke, et al.
Publicado: (2023)

Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
por: Miyatani, Yusuke, et al.
Publicado: (2023)

Validation of a claims‐based algorithm to identify cases of ulcerative colitis in Japan
por: Ogino, Haruei, et al.
Publicado: (2021)

Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
por: Kobayashi, Taku, et al.
Publicado: (2019)

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
por: Hisamatsu, Tadakazu, et al.
Publicado: (2021)

Acceptability of endoscopic submucosal dissection for sessile serrated lesions: comparison with non-sessile serrated lesions
por: Kuroki, Yuichiro, et al.
Publicado: (2020)

Impact of oligomeric enteral nutrition with low-molecular-weight whey peptides on diarrhea in critical care nutrition
por: Nakamura, Kensuke, et al.
Publicado: (2022)

Concurrent Resolution of Chronic Diarrhea Likely Due to Crohn’s Disease and Infection with Mycobacterium avium paratuberculosis
por: Singh, Shoor V., et al.
Publicado: (2016)

Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
por: Tajiri, Hitoshi, et al.
Publicado: (2018)

Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
por: Tajiri, Hitoshi, et al.
Publicado: (2022)

Intestinal spirochetosis: An unusual cause of postantibiotic diarrhea
por: Matsuda, Hideshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q15k728efbuul6a18knlqj2tm0